US health regulators create a new fast lane for prostate devices

US health regulators just created a new, faster approval path for a specific type of prostate device. This means companies can get these devices to market more quickly, reducing the time and cost of regulatory review.

Getting a new medical device approved in the US is a long, expensive process. This new rule carves out a specific category of device and assigns it to a lower-risk class. This makes it easier and cheaper for companies to bring these devices to patients. It also signals that regulators are willing to create specific pathways for certain innovations, rather than forcing all new devices through the same slow process.